Skip to main content
CRM
NYSE Technology

Salesforce Defends Equity Plan Share Increase Against ISS Opposition, Citing Buyback Offset

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$178
Mkt Cap
$146.775B
52W Low
$163.52
52W High
$289.9
52W Position info
8.9% above low
Off High info
39% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CRM is trading near its 52-week low of $163.52 (8.9% above the low).

Summary

Salesforce filed a proxy supplement to defend its proposal to add 34 million shares to its equity incentive plan, countering ISS's recommendation against it by highlighting its recent, larger share buyback program.


Key Events · Corporate Governance and Compliance · CRM

  • Equity Incentive Plan Amendment

    Salesforce is requesting shareholder approval to add 34 million shares to its 2013 Equity Incentive Plan.

  • ISS Recommendation Against Proposal

    Institutional Shareholder Services (ISS) has recommended that stockholders vote against Proposal 2, citing concerns over Shareholder Value Transfer (SVT).

  • Company Defends Proposal with Buyback Offset

    Salesforce argues that its recent $25 billion accelerated share repurchase program, which retired 103 million shares, more than offsets the dilutive impact of the 34 million shares requested.

  • Rationale for Share Increase

    The company states the share request is crucial for attracting and retaining specialized talent in the competitive AI and cloud computing market, ensuring strategic continuity.


Analysis · CRM · Technology

Salesforce is seeking shareholder approval to add 34 million shares to its equity incentive plan. This proposal is significant because Institutional Shareholder Services (ISS) has recommended against it, prompting Salesforce to issue this supplement to defend its position. The company argues that its recent $25 billion accelerated share repurchase program, which retired 103 million shares, more than offsets the dilutive impact of the 34 million shares requested, resulting in a net reduction of shares outstanding. This is a key vote for the upcoming annual meeting, impacting future employee compensation and potential dilution.

How filings like this one have moved

In the 30 days to Nov 2, 2026, 32.7% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRM was trading at $178.00 on NYSE in the Technology sector, with a market capitalization of approximately $146.8B. The 52-week trading range was $163.52 to $289.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRM - Latest Insights

CRM
Oct 29, 2026, 4:00 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $231.04
Real-time Price: $228.52 info
Change: -$2.52 (-1%) info
Market Cap: $188.607B info
CRM
Oct 20, 2026, 9:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $235.45
Real-time Price: $228.52 info
Change: -$6.93 (-3%) info
Market Cap: $188.607B info
CRM
Oct 12, 2026, 8:42 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $238.41
Real-time Price: $228.52 info
Change: -$9.89 (-4%) info
Market Cap: $188.607B info
CRM
Sep 17, 2026, 3:06 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $251.14
Real-time Price: $228.52 info
Change: -$22.62 (-9%) info
Market Cap: $188.607B info
CRM
Sep 16, 2026, 9:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $251.15
Real-time Price: $228.52 info
Change: -$22.63 (-9%) info
Market Cap: $188.607B info